Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-015629
Filing Date
2024-11-14
Accepted
2024-11-14 09:10:11
Documents
88
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q btai-20240930x10q.htm   iXBRL 10-Q 2542716
2 EX-10.4 btai-20240930xex10d4.htm EX-10.4 22156
3 EX-10.5 btai-20240930xex10d5.htm EX-10.5 22170
4 EX-10.6 btai-20240930xex10d6.htm EX-10.6 22188
5 EX-10.7 btai-20240930xex10d7.htm EX-10.7 22316
6 EX-31.1 btai-20240930xex31d1.htm EX-31.1 17385
7 EX-31.2 btai-20240930xex31d2.htm EX-31.2 17604
8 EX-32.1 btai-20240930xex32d1.htm EX-32.1 10365
9 EX-32.2 btai-20240930xex32d2.htm EX-32.2 8798
10 GRAPHIC btai-20240930x10q006.jpg GRAPHIC 89666
11 GRAPHIC btai-20240930x10q007.jpg GRAPHIC 80261
  Complete submission text file 0001558370-24-015629.txt   9688824

Data Files

Seq Description Document Type Size
12 EX-101.SCH btai-20240930.xsd EX-101.SCH 52094
13 EX-101.CAL btai-20240930_cal.xml EX-101.CAL 46161
14 EX-101.DEF btai-20240930_def.xml EX-101.DEF 250761
15 EX-101.LAB btai-20240930_lab.xml EX-101.LAB 499697
16 EX-101.PRE btai-20240930_pre.xml EX-101.PRE 398845
91 EXTRACTED XBRL INSTANCE DOCUMENT btai-20240930x10q_htm.xml XML 1403813
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

EIN.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38410 | Film No.: 241457647
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)